« Back to Record
Citation APA

MacHa, A., Liebsch, F., Fricke, S., Hetsch, F., Neuser, F., Johannes, L., Kress, V., Djemie, T., Santamaria-Araujo, J. A., Vilain, C., Aeby, A., Van Bogaert, P., Dejanovic, B., Weckhuysen, S., Meier, J. J., & Schwarz, G. (2022). Biallelic gephyrin variants lead to impaired GABAergic inhibition in a patient with developmental and epileptic encephalopathy. Human molecular genetics, 31(6), 901-913. doi:10.1093/hmg/ddab298


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/342456

MacHa, A., Liebsch, F., Fricke, S., Hetsch, F., Neuser, F., Johannes, L., Kress, V., Djemie, T., Santamaria-Araujo, J. A., Vilain, C., Aeby, A., Van Bogaert, P., Dejanovic, B., Weckhuysen, S., Meier, J. J., & Schwarz, G. (2022). Biallelic gephyrin variants lead to impaired GABAergic inhibition in a patient with developmental and epileptic encephalopathy. Human molecular genetics, 31(6), 901-913. doi:10.1093/hmg/ddab298